tiprankstipranks
GenSight Biologics SA (DE:G49N)
FRANKFURT:G49N
Germany Market
G49N
GenSight Biologics SA
RESEARCH TOOLSreports

GenSight Biologics SA (G49N) Income Statement

1 Followers

GenSight Biologics SA Income Statement

Last quarter (Q4 2025), GenSight Biologics SA's total revenue was €-47.00K, a decrease of -103.24% from the same quarter last year. In Q4, GenSight Biologics SA's net income was €-5.07M. See GenSight Biologics SA’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
€ 1.00K€ 2.63M€ 1.27M€ 2.58M€ 5.28M
Gross Profit
€ 0.00€ 2.63M€ 3.00M€ 2.58M€ 5.28M
Operating Expenses
€ 11.24M€ 18.44M€ 32.66M€ 30.42M€ 33.40M
Depreciation and Amortization
€ 465.00K€ 1.06M€ 3.03M€ 1.06M€ 928.00K
EBITDA
€ -11.24M€ -14.76M€ -21.73M€ -26.77M€ -25.52M
Operating Income
€ -11.71M€ -15.81M€ -29.70M€ -27.84M€ -28.13M
Other Income/Expenses
€ -336.00K€ 1.83M€ 3.48M€ 215.00K€ -489.00K
Pretax Income
€ -12.04M€ -13.98M€ -26.22M€ -27.62M€ -28.61M
Net Income
€ -12.04M€ -14.00M€ -26.22M€ -27.62M€ -28.62M
Per Share Metrics
Basic EPS
€ -0.08€ -0.15€ -0.54€ -0.60€ -0.63
Diluted EPS
€ -0.08€ -0.15€ -0.54€ -0.60€ -0.63
Weighted Average Shares Outstanding
 148.30M 95.76M 48.32M 46.33M 45.15M
Weighted Average Shares Outstanding (Diluted)
 148.30M 95.76M 48.32M 46.33M 45.15M
Currency in EUR

GenSight Biologics SA Earnings and Revenue History